1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Program closed; five consortia were awarded in March 2025. No open deadline.
NWO-KIC: Antimicrobials for the preclinical pipeline is sponsored by Dutch Research Council (NWO) and the Ministry of Health, Welfare and Sport (VWS). This program funds public-private collaborations to develop new antimicrobials and complementary therapies against bacterial and fungal infections in humans.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Antimicrobials for the preclinical pipeline | NWO The objective of the KIC ‘Antimicrobials for the preclinical pipeline’ is to fund research from public-private collaborations. The collaborations will focus on filling the preclinical pipeline with potential new agents or therapies against human bacterial and fungal infections to further combat AMR.
The focus is on the use and application of knowledge that can be translated into (pre-)clinical research within a reasonable time frame. Bringing together researchers and companies in consortia will encourage collaborative research and minimise the economic challenges and risks of developing new antimicrobial agents.
NWO and the Ministry of Health, Welfare and Sport are jointly providing a total of 8 million euros for the research programme. A minimum of 750,000 euros and a maximum of 1,000,000 euros of NWO funding can be requested for a research proposal in this round. The maximum duration of the projects is six years.
This KIC call is being funded by NWO and the Ministry of Health, Welfare and Sport . Connection to research agendas This call originates from the Knowledge and Innovation Agenda (KIA) for Health and Care [Dutch only]. The central mission of this KIA is ‘Longer healthy living’.
Bringing innovation to life and working towards the intended impact of the KIC missions will place high demands on the Dutch workforce in the coming years. Targeted efforts and new knowledge in the field of learning, working and innovation are needed to bring the workforce potential up to the required level and to increase the innovative power.
Human Capital focuses on this issue and is therefore an important spearhead in the KIC to make innovation policy a success. More information about Human Capital Five public-private consortia launch research into solutions for antimicrobial resistance Call open for research on antimicrobials
According to the current listing, eligibility includes: Consortia of researchers, doctors, and partners from international research institutes, hospitals, private companies, and civil society organizations. Confirm the full requirements in the official notice before applying.
The current listing shows total program budget of €8 million; €750,000 to €1,000,000 of NWO funding per research proposal. Verify award ceilings, matching requirements, and allowable costs in the official notice.
NWO-KIC: Antimicrobials for the preclinical pipeline is funded by Dutch Research Council (NWO) and the Ministry of Health, Welfare and Sport (VWS). Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Gates Foundation committed at least $1 billion over two years to equitable AI alongside its 10th Goalkeepers Report — 40% education, 40% health, 10% agriculture, 10% digital infrastructure. Five days later, 60 organizations signed a five-year goal to reach 3.4 billion speakers of underrepresented languages. Here is how implementing nonprofits should read both.
Read articleThe Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read article